Pricing Log in Create free account

Rein Therapeutics Inc. (RNTX) vs Tenax Therapeutics, Inc. (TENX)

Rein Therapeutics Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Rein Therapeutics Inc. and Tenax Therapeutics, Inc. are of similar size ($56.5M and $54.2M). Across the 9 metrics below, Tenax Therapeutics, Inc. leads on 5 and Rein Therapeutics Inc. on 4.

Valuation

Metric RNTX TENX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 201.11 9.71
P/B 3.88 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.03 0.71 0.64
EV/Sales n/m (141.75) 9.21
Earnings yield (291.53%) (108.82%) (33.15%)
Free cash flow yield (47.32%) (66.58%) (25.50%)

Profitability

Metric RNTX TENX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (753.55%) (59.80%) (56.36%)
Return on assets (80.62%) (57.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RNTX TENX Biotechnology median
Revenue growth (TTM) — (70.77%) 6.02%
EPS growth (last fiscal year) 44.16% (16.52%) 30.26%
Revenue growth, 5-year CAGR — 0.79% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RNTX TENX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.27 15.07 4.72
Net debt to EBITDA 0.15 1.73 0.96

Dividend

Metric RNTX TENX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric RNTX TENX Biotechnology median
Market cap 54.17m 56.51m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack